Evidence map›Paper›PMID 32537420›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2020

Bioinspired One Cell Culture Isolates Highly Tumorigenic and Metastatic Cancer Stem Cells Capable of Multilineage Differentiation.

Hai Wang, Pranay Agarwal, Bin Jiang, Samantha Stewart, Xuanyou Liu, Yutong Liang, Baris Hancioglu, Amy Webb, John P Fisher, Zhenguo Liu and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Hai WangFischell Department of Bioengineering University of Maryland College Park MD 20742 USA.
Pranay AgarwalDepartment of Biomedical Engineering The Ohio State University Columbus OH 43210 USA.
Bin JiangFischell Department of Bioengineering University of Maryland College Park MD 20742 USA.
Samantha StewartFischell Department of Bioengineering University of Maryland College Park MD 20742 USA.
Xuanyou LiuDivision of Cardiovascular Medicine Center for Precision Medicine University of Missouri School of Medicine Columbia MO 65212 USA.
Yutong LiangFischell Department of Bioengineering University of Maryland College Park MD 20742 USA.
Baris HanciogluDepartment of Biomedical Informatics The Ohio State University Columbus OH 43210 USA.
Amy WebbDepartment of Biomedical Informatics The Ohio State University Columbus OH 43210 USA.
John P FisherFischell Department of Bioengineering University of Maryland College Park MD 20742 USA.
Zhenguo LiuDivision of Cardiovascular Medicine Center for Precision Medicine University of Missouri School of Medicine Columbia MO 65212 USA.
Xiongbin LuDepartment of Medical and Molecular Genetics and Melvin and Bren Simon Cancer Center Indiana University School of Medicine Indianapolis IN 46202 USA.
Katherine H R TkaczukMarlene and Stewart Greenebaum Comprehensive Cancer Center University of Maryland Baltimore MD 21201 USA.
Xiaoming HeFischell Department of Bioengineering University of Maryland College Park MD 20742 USA.ORCID https://orcid.org/0000-0003-0125-6086
University of Maryland, College Park · USThe Ohio State University · USPrecision for Medicine (United States) · USUniversity of Maryland, Baltimore · USIndiana University Health · USNational Center for Nanoscience and Technology · CN

Funding

Oxidized Low-density Lipoprotein Impairs Bone Marrow Stem Cell SurvivalR01HL124122 · NHLBI · OHIO STATE UNIVERSITY · PI LIU, ZHENGUO, ZHU, HUA · 2015 to 2018
$2.1M
Nanotechnology for targeted therapy and fundamental understanding oftherapeutic resistance in triple negative breast cancerR01CA243023 · NCI · UNIV OF MARYLAND, COLLEGE PARK · PI HE, XIAOMING · 2020 to 2024
$2.0M
Nanotechnology enabled targeting of p53 deficiency in human cancerR01CA206366 · NCI · UNIV OF MARYLAND, COLLEGE PARK · PI HE, XIAOMING, LU, XIONGBIN · 2016 to 2020
$1.9M
Ambient fine particulate matter and bone marrow stem cellsR01ES026200 · NIEHS · UNIVERSITY OF MISSOURI-COLUMBIA · PI LIU, ZHENGUO · 2016 to 2020
$1.7M
NCI NIH HHS R01 CA206366NCI NIH HHS R01 CA243023NHLBI NIH HHS R01 HL124122NIEHS NIH HHS R01 ES026200
6 · The paper itself

Abstract

Cancer stem cells (CSCs) are rare cancer cells that are postulated to be responsible for cancer relapse and metastasis. However, CSCs are difficult to isolate and poorly understood. Here, a bioinspired approach for label-free isolation and culture of CSCs, by microencapsulating one cancer cell in the nanoliter-scale hydrogel core of each prehatching embryo-like core-shell microcapsule, is reported. Only a small percentage of the individually microencapsulated cancer cells can proliferate into a cell colony. Gene and protein expression analyses indicate high stemness of the cells in the colonies. Importantly, the colony cells are capable of cross-tissue multilineage (e.g., endothelial, cardiac, neural, and osteogenic) differentiation, which is not observed for "CSCs" isolated using other contemporary approaches. Further studies demonstrate the colony cells are highly tumorigenic, metastatic, and drug resistant. These data show the colony cells obtained with the bioinspired one-cell-culture approach are truly CSCs. Significantly, multiple pathways are identified to upregulate in the CSCs and enrichment of genes related to the pathways is correlated with significantly decreased survival of breast cancer patients. Collectively, this study may provide a valuable method for isolating and culturing CSCs, to facilitate the understanding of cancer biology and etiology and the development of effective CSC-targeted cancer therapies.

Indexed as

cancer stem cellsdifferentiationdrug resistancemetastasismicrofluidics

Identifiers

PMID32537420
PMCPMC7284220
OpenAlexW3021205417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.